EUVIMEDEUVIMED entdecken
Crossref

A mutant recombinant human endostatin containing the RGDRGD sequence suppresses tumor growth in a mouse xenograft model: Int J Clin Exp Pathol. 2017; 10(6): 6727-6734

Minghua Ren

International Journal of Clinical and Experimental Pathology · 2024

DOI: 10.62347/afyj3936 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical and Experimental Pathology, 2024. Verfasst von Minghua Ren.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ren, M. (2024). A mutant recombinant human endostatin containing the RGDRGD sequence suppresses tumor growth in a mouse xenograft model: Int J Clin Exp Pathol. 2017; 10(6): 6727-6734. International Journal of Clinical and Experimental Pathology. https://doi.org/10.62347/afyj3936

Vancouver

Ren M. A mutant recombinant human endostatin containing the RGDRGD sequence suppresses tumor growth in a mouse xenograft model: Int J Clin Exp Pathol. 2017; 10(6): 6727-6734. International Journal of Clinical and Experimental Pathology. 2024. doi:10.62347/afyj3936

BibTeX
@article{Ren2024,
  author = {Ren, Minghua},
  title = {A mutant recombinant human endostatin containing the RGDRGD sequence suppresses tumor growth in a mouse xenograft model: Int J Clin Exp Pathol. 2017; 10(6): 6727-6734},
  journal = {International Journal of Clinical and Experimental Pathology},
  year = {2024},
  doi = {10.62347/afyj3936}
}
Kostenlos starten →